Dr. Young E Whang MD
Hematologist-Oncologist | Hematology & Oncology
101 Manning Dr Chapel Hill NC, 27599About
Dr. Young Whang is a hematologist oncologist practicing in Chapel Hill, NC. Dr. Whang specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Univ of Chicago, Pritzker Sch of Med, Chicago Il 1989
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Internal MedicineAmerican Board of Internal MedicineABIM- 1993
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology- 1996
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2.
- Role of phosphoinositide 3-kinase in the aggressive tumor growth of HT1080 human fibrosarcoma cells.
- PTEN blocks tumor necrosis factor-induced NF-kappa B-dependent transcription by inhibiting the transactivation potential of the p65 subunit.
- PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway.
- Hypertriglyceridemia and pancreatitis associated with estramustine phosphate.
- The PTEN tumor suppressor is a negative modulator of androgen receptor transcriptional activity.
- Heregulin-induced activation of HER2 and HER3 increases androgen receptor transactivation and CWR-R1 human recurrent prostate cancer cell growth.
- Inhibition of HER-2/neu kinase impairs androgen receptor recruitment to the androgen responsive enhancer.
- Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines.
- Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability.
- The impact of altered annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells.
- Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.
- Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases.
- A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer.
Professional Memberships
- Member North Carolina Oncology Association
- Member American Association for Cancer Research
- Member American Society of Clinical Oncology
Fellowships
- UCLA Medical Center, Hematology/Oncology, CA, USA 1996
- University of California, Los Angeles, CA, Hematology/Oncology 1993
Dr. Young E Whang MD's Practice location
Chapel Hill, NC 27599Get Direction
Dr. Young E Whang MD's reviews
Write ReviewPatient Experience with Dr. Whang
Recommended Articles
- Nurse Donates Breast Milk for Lymphoma Patient's Baby
Ashley Chestnut, a mother of two children from La Vista, Nebraska, was breastfeeding her 5-month-year-old son Easton when she began to experience a sharp and sudden pain in her shoulder and chest. “All of a sudden a sharp pain in my shoulder and chest, it was like hitting a freight train. It was...
- Can Multiple Myeloma be Asymptomatic?
Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...
- Inspirational Blood Cancer Survivors
Different forms of blood cancer are responsible for claiming the third most lives out of all the types of cancer. Additionally, there are currently no known preventative treatments for blood cancers, and the disease also impacts children and young people more than any other form of cancer.When it...
- Breaking News on the Treatment of Follicular Lymphoma
Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...
- Exercise Proven to Help Lymphoma Patients
People always say that exercise is the best medicine. It's been proven through many years of research that regular exercise is really important to maintain a healthy body and mind. Doctors are always reminding their patients of the benefits of physical exercise and the power it holds to fight...
- New Diagnostic Tool Approved for Lymphoma
A new diagnostic tool has been approved by the U.S. Food and Drug Administration (FDA) to help researchers identify leukemia and lymphoma cells by using a technique known as flow cytometry. A flow cytometry test for non-Hodgkin’s lymphoma (NHL) can help determine whether normal or abnormal DNA is...
Nearby Providers
- Dr. Nicole Kuderer M.D.PO Box Dumc Durham NC 27710
- Dr. Nicole Lemieux Whitlatch MDDumc 3841 Durham NC 27710
- Dr. Paul Marcom M.D.4101 N Roxboro St Durham NC 27704
- Dr. Matthew Stuart Mckinney M.D.40 Duke Medicine Cir Durham NC 27710
- Dr. Neil L Spector MD4101 N Roxboro St Durham NC 27704
- Dr. Ivy P Altomare MD40 Duke Medicine Cir Durham NC 27710